Biden Allocates $150M for Advanced Cancer Surgery Tech

President Joe Biden is allocating $150 million towards new technology for improving surgical removal of cancerous tumors. This funding, part of the 'Cancer Moonshot' initiative, aims to halve the U.S. cancer death rate by 2047. The investment will enhance imaging technology to reduce repeat surgeries and preserve healthy tissue.

President Joe Biden will announce Tuesday a $150 million federal investment to develop advanced technology for more effective surgical removal of cancerous tumors, according to the White House.

Scheduled to be unveiled during Biden's visit to New Orleans, this funding is the latest boost to the 'Cancer Moonshot' initiative, a program driven by Biden and the First Lady to decrease the U.S. cancer death rate by at least half by 2047. Over two million Americans are diagnosed with solid tumors annually, and surgery is frequently the primary treatment.

Enhanced microscopes and imaging technology funded by this initiative aim to improve surgical outcomes, reduce the need for subsequent procedures, and minimize harm to healthy tissue, thereby saving and extending lives. In its initial two years, the administration has dedicated over $400 million to accelerate advancements in cancer prevention, detection, and treatment, according to the White House. Award recipients include renowned institutions such as Dartmouth College, Johns Hopkins University, and the University of Washington.

(With inputs from agencies.)